Gabelli & Co Investment Advisers’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-142,800	Closed	-$1.46M	–	309
2023 Q3	$1.46M	Buy	+142,800	New	+$1.09M	0.24%	64

Gabelli & Co Investment Advisers's THRN Position: Q4 2023 in Review

Gabelli & Co Investment Advisers sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 142,800 shares — an estimated $1.46M sold.

Gabelli & Co Investment Advisers first reported a position in THRN in Q3 2023 and held it in 1 quarter. The position peaked at $1.46M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Gabelli & Co Investment Advisers reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 142,800 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $1.46M.
Gabelli & Co Investment Advisers first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Thorne Healthtech, Inc. Common Stock position peaked at $1.46M in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.